These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2374271)

  • 1. Benzodiazepines in a health-catalog product.
    DuPont RL; Bogema SC
    JAMA; 1990 Aug; 264(6):695. PubMed ID: 2374271
    [No Abstract]   [Full Text] [Related]  

  • 2. Interference of oxaprozin with benzodiazepines via enzyme immunoassay technique.
    Matuch-Hite T; Jones P; Moriarity J
    J Anal Toxicol; 1995; 19(2):130. PubMed ID: 7769785
    [No Abstract]   [Full Text] [Related]  

  • 3. [Application of extraction freezing for analysis of 1,4-benzodiazepines in urine].
    Bekhterev VN; Gavrilova SN; Maslakov IV
    Sud Med Ekspert; 2007; 50(2):32-5. PubMed ID: 17520905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine Drug Testing in a Family Medicine Residency Practice.
    Woodall HE; Young N; Davis A; Wright MB
    J Addict Med; 2017; 11(3):242-243. PubMed ID: 28557961
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of benzodiazepine abuse in opiate addicts.
    Browne R; Sloan D; Fahy S; Keating S; Moran C; O'Connor J
    Ir Med J; 1998; 91(1):18-9. PubMed ID: 9563249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Unexpected Urine Test: A Matter Far From Simple.
    Kertesz SG
    J Addict Med; 2017; 11(6):417-419. PubMed ID: 28953503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunochemical screening: manipulation, handling and interpretation errors, exemplified by benzodiazepines].
    Schütz H; Verhoff MA; Erdmann F; Weiler G
    Arch Kriminol; 2003; 212(5-6):141-50. PubMed ID: 14723121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic agents off the darknet: a case of U-47700 and phenazepam abuse.
    Vo KT; van Wijk XM; Wu AH; Lynch KL; Ho RY
    Clin Toxicol (Phila); 2017 Jan; 55(1):71-72. PubMed ID: 27736261
    [No Abstract]   [Full Text] [Related]  

  • 9. Urinary screening for benzodiazepines with radioreceptor assay: comparison with EMIT d.a.u. benzodiazepine assay and high-performance liquid chromatography.
    Borggaard B; Joergensen I
    J Anal Toxicol; 1994 Sep; 18(5):243-6. PubMed ID: 7990439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary amphetamines, benzodiazepines and methadone: cost-effective detection procedures.
    Moore FM; Jarvie DR; Simpson D
    Med Lab Sci; 1992 Mar; 49(1):27-33. PubMed ID: 1453905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of the accuracy of benzodiazepine testing in chronic pain patients utilizing immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(3):259-70. PubMed ID: 21587329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of benzodiazepines in urine via benzophenone derivatives using liquid chromatography-tandem mass spectrometry.
    Roškar R; Sollner Dolenc M
    Arh Hig Rada Toksikol; 2010 Dec; 61(4):381-8. PubMed ID: 21183429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dried urine spots for detection of benzodiazepines.
    Jain R; Quraishi R; Ambekar A; Verma A; Gupta P
    Indian J Pharmacol; 2017; 49(6):465-469. PubMed ID: 29674802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3 things to consider before relying solely on point of care tests for determining benzodiazepine use in chronic pain.
    Mikel C; Pesce A; West C
    Pain Physician; 2012; 15(2):E154-5; author reply E155-6. PubMed ID: 22430663
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of Benzodiazepines for Drug-Facilitated Assaults and Abuse Settings (Urine).
    Drummer OH; Di Rago M; Gerostamoulos D
    Methods Mol Biol; 2019; 1872():23-39. PubMed ID: 30350276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzodiazepines in Miami-Dade County, Florida driving under the influence (DUI) cases (1995-1998) with emphasis on Rohypnol: GC-MS confirmation, patterns of use, psychomotor impairment, and results of Florida legislation.
    Raymon LP; Steele BW; Walls HC
    J Anal Toxicol; 1999 Oct; 23(6):490-9. PubMed ID: 10517556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LC-(TOF) MS analysis of benzodiazepines in urine from alleged victims of drug-facilitated sexual assault.
    ElSohly MA; Gul W; Murphy TP; Avula B; Khan IA
    J Anal Toxicol; 2007 Oct; 31(8):505-14. PubMed ID: 17988465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing false-negative tests in urinary drugs-of-abuse screening.
    Luceri F; Godi F; Messeri G
    J Anal Toxicol; 1997; 21(3):244-5. PubMed ID: 9171214
    [No Abstract]   [Full Text] [Related]  

  • 19. Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays.
    Pettersson Bergstrand M; Helander A; Hansson T; Beck O
    Drug Test Anal; 2017 Apr; 9(4):640-645. PubMed ID: 27366870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary comparative study on the usefulness of instant-view'TM M-1 and Triage DOA in testing for drugs-of-abuse in forensic urine samples].
    Moriya F
    Chudoku Kenkyu; 2012 Sep; 25(3):243-6. PubMed ID: 23057404
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.